Related Research Articles
Sidney Farber was an American pediatric pathologist. He is regarded as the father of modern chemotherapy for his work using folic acid antagonists to combat leukemia,which led to the development of other chemotherapeutic agents against other malignancies. Farber was also active in cancer research advocacy and fundraising,most notably through his establishment of the Jimmy Fund,a foundation dedicated to pediatric research in childhood cancers. The Dana–Farber Cancer Institute is named after him.
Josep Baselga i Torres,known in Spanish as JoséBaselga was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents,with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center,Vall d'Hebron Institute of Oncology,and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin,a monoclonal antibody,that targets the HER2 protein which is impacted in aggressive breast cancers.
Timothy J. Ley is an American hematologist and cancer biologist. He is the Lewis T. and Rosalind B. Apple Professor of Oncology in the Department of Medicine,and is chief of the Section of Stem Cell Biology in the Division of Oncology at Washington University in St. Louis. He is a member of the Alvin J. Siteman Cancer Center.
George Quentin Daley is the Dean of the Faculty of Medicine,Caroline Shields Walker Professor of Medicine,and Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School,Director of the Stem Cell Transplantation Program at Boston Children's Hospital,and an investigator of the Howard Hughes Medical Institute,Associate Director of Children's Stem Cell Program,a member of the Executive Committee of the Harvard Stem Cell Institute. He is a past president of the International Society for Stem Cell Research (2007–2008).
Leonard I. Zon,M.D.,is the Grousbeck Professor of Pediatric Medicine at Harvard Medical School,Investigator at Howard Hughes Medical Institute,and Director of the Stem Cell Program,Children’s Hospital Boston.
Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the director of the Susan F. Smith Center for Women's Cancer.
Kenneth Offit is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute,Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College,and a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.
Stuart Holland Orkin is an American physician,stem cell biologist and researcher in pediatric hematology-oncology. He is the David G. Nathan Distinguished Professor of Pediatrics at Harvard Medical School. Orkin's research has focused on the genetic basis of blood disorders. He is a member of the National Academy of Sciences and the Institute of Medicine,and an Investigator of the Howard Hughes Medical Institute.
Kenneth C. Anderson is an American hematologist-oncologist and cancer researcher who is primarily known for advances in the treatment of multiple myeloma. He directs the Lebow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center at Dana–Farber Cancer Institute and is the Kraft Family Professor of Medicine and Vice Chair of the Joint Program in Transfusion Medicine at Harvard Medical School.
Christoph Klein is a German Pediatric Hematologist/Oncologist and Director at the Dr. von Hauner Children’s Hospital,Ludwig-Maximilians-Universität Munich,Germany.
Robert Maki is an American medical oncologist,Professor of Medicine at the Hospital of the University of Pennsylvania,He is a specialist in the management of and translational research regarding sarcoma,the group of connective tissue malignancies that include leiomyosarcoma,gastrointestinal stromal tumor (GIST),liposarcoma,angiosarcoma,Ewing sarcoma,desmoid tumor and many others.
A. Thomas Look is Professor of Pediatrics at Harvard Medical School and Vice-Chair for Research,Pediatric Oncology,Dana–Farber Cancer Institute. He is a pioneer in the use of zebrafish in cancer research and made major contributions to the understanding of leukemia and neuroblastoma biology and pathogenesis.
Philip W. Kantoff is a medical oncologist. He is the chairman and chief executive officer (CEO) of Convergent Therapeutics. He served as the Chairman of Medicine at Memorial Sloan Kettering Cancer Center between 2015 and 2021. He is best known for his contributions to the impact of DNA abnormalities in prostate cancer and the discovery of therapies for metastatic hormone-sensitive prostate cancer.
Catherine J. Wu is an American physician-scientist who studies oncology. She is a Professor of Medicine and Chief of Division of Stem Cell Transplantation and Cellular Therapies at the Dana–Farber Cancer Institute. Her research focuses on longitudinal studies of patients with chronic lymphocytic leukemia (CLL).
Nirali N. Shah is an American physician-scientist and pediatric hematologist-oncologist,serving as head of the hematologic malignancies section of the pediatric oncology branch at the National Cancer Institute. She researches the translation of immunotherapeutic approaches to treat high-risk hematologic malignancies in children,adolescents and young adults.
Stephan A. Grupp is an American pediatric oncologist. He is the Chief of the Cell Therapy and Transplant Section in the Division of Oncology and Director of the Cancer Immunotherapy Program at the Children's Hospital of Philadelphia and Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. In 2019,Grupp was elected a Member of the National Academy of Medicine.
Levi A. Garraway is an American oncologist. His research team was among the first to adapt genomics technologies to enable scalable,high-throughput clinical approaches to cancer gene mutation profiling. As a result,he was inducted into the American Society for Clinical Investigation,American Association for Cancer Research,and National Academy of Medicine.
Bob Löwenberg is a clinical hematologist/investigator. He is Professor of Hematology at Erasmus University Rotterdam.
Matthew Langer Meyerson is an American pathologist and the Charles A. Dana Chair in Human Cancer Genetics at the Dana-Farber Cancer Institute. He is also director of the Center for Cancer Genomics at the Dana-Farber Cancer Institute,and the Director of Cancer Genomics at the Broad Institute of MIT and Harvard.
Benjamin Levine Ebert is the Chair of Medical Oncology at the Dana–Farber Cancer Institute and the George P. Canellos,MD and Jean S. Canellos Professor of Medicine at Harvard Medical School.
References
- ↑ Stevens, Courtney (January 16, 2010). "Offering a chance to change the world". The Daily Oklahoman. Retrieved May 28, 2021– via newspapers.com.
- ↑ "Armstrong completes M.D./Ph.D degrees". Okmulgee Daily Times. June 16, 1996. Retrieved May 28, 2021– via newspapers.com.
- ↑ "Scott Armstrong, MD, PhD: 2000 ASH Scholar". hematology.org. Retrieved May 28, 2021.
- ↑ "Diagnosis by database shows promise". Harvard Gazette. December 14, 2001. Retrieved May 28, 2021.
- ↑ "Scientists using gene chips identify unique form of leukemia". Harvard Gazette. December 3, 2001. Retrieved May 28, 2021.
- 1 2 "ASH honors Scott Armstrong, M.D., Ph.D., with 2014 William Dameshek Prize". eurekalert.org. Eurekalert. July 22, 2014. Retrieved May 28, 2021.
- 1 2 "Three Young Investigators Named Winners of Paul Marks Prize for Cancer Research". mskcc.org. September 20, 2011. Retrieved May 28, 2021.
- ↑ "Scott A. Armstrong, MD, PhD". the-asci.org. Retrieved May 28, 2021.
- ↑ "Epigenetic pathway and new drug show promise in reversing a hard-to-treat childhood cancer". dana-farber.org. July 11, 2011. Retrieved May 28, 2021.
- ↑ "Scott Armstrong and Kitai Kim Named to Endowed Chairs". mskcc.org. November 1, 2012. Retrieved May 28, 2021.
- ↑ "Scott A. Armstrong to lead Department of Pediatric Oncology at Dana–Farber Cancer Institute". newswise.com. March 29, 2016. Retrieved May 28, 2021.
- ↑ "Three Dana-Farber faculty members elected to National Academy of Medicine". dana-farber.org. October 16, 2017. Retrieved May 28, 2021.
- ↑ "ISSCR Announces 2019 Award Recipients". isscr.org. February 8, 2019. Retrieved May 28, 2021.
